About
Esperovax develops proprietary oral mRNA vaccine platforms designed to produce thermostable, cost-effective, and easily distributable oral biologics for preventing and treating infectious diseases.
Explore Esperovax's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.